Dihydronicotyrine

Dihydronicotyrine

SCHEMBL1207625

C1=C(c2cccnc2)NCC1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 9/20 0.52
▸ ALDH1A1 P00352 4/20 0.52
▸ CYP3A4 P08684 4/20 0.52
▸ CYP1A2 P05177 3/20 0.52
▸ NISCH Q9Y2I1 1/20 0.49
▸ CYP2E1 P05181 3/20 0.47
▸ CYP2B6 P20813 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ CHRNB2 P17787 1/20 0.44
▸ CHRNA3 P32297 1/20 0.44
▸ CHRNA4 P43681 1/20 0.44
▸ CYP2C19 P33261 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10017294 0.89 CYP2A6 (0.48) CYP2A6ALDH1A1CYP3A4CYP1A2NISCH
SCHEMBL7163648 0.77 NISCH (0.39) ALDH1A1NISCHKDM4EMAPTHPGD
SCHEMBL5171062 0.75 CYP2A6 (0.61) CYP2A6ALDH1A1CYP3A4CYP1A2NISCH
SCHEMBL31038279 0.75 NISCH (0.36) NISCHKDM4EMAPT
SCHEMBL30269982 0.73 HTR2A (0.49) CYP2A6ALDH1A1CYP3A4CYP1A2NISCH
SCHEMBL4790022 0.73 HTR2A (0.49) CYP2A6ALDH1A1CYP3A4CYP1A2NISCH
SCHEMBL16272068 0.72 ALDH1A1 (0.45) CYP2A6ALDH1A1CYP3A4CYP1A2NISCH
SCHEMBL30473120 0.71 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2CYP2E1
SCHEMBL29419014 0.71 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2CYP2E1
SCHEMBL120088 0.71 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1630 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361222-A1 Extraction of nicotine from tobacco by closed cycle steam stripping and scrubbing SAMULIS LEOPOLD (GB) 2025-11-27 — — US claimed
EP-4651705-A1 METHOD Nicoventures Trading Limited (GB) 2025-11-26 — — EP claimed
US-20250304984-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-10-02 — — US claimed
US-20250283103-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-09-11 — — US claimed
US-20250283101-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-09-11 — — US claimed
US-20250243499-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-07-31 — — US claimed
US-20250243500-A1 METHOD FOR MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (US) 2025-07-31 — — US claimed
US-20250230457-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-07-17 — — US claimed
US-20250215443-A1 METHOD OF MODULATING ALKALOID CONTENT IN TOBACCO PLANTS Nicoventures Trading Limited (GB) 2025-07-03 — — US claimed
CN-118005607-B Process for the preparation of (S) -nicotine from myosmine 扎诺普瑞玛生命科学有限公司 2025-06-17 — — CN claimed
EP-1675454-A1 REDUCED-EXPOSURE TOBACCO PRODUCTS 22nd Century Limitel, LLC (US) 2006-07-05 — — EP claimed
WO-2005023942-A2 MATERIALS AND METHODS FOR INHIBITING FOULING OF SURFACES EXPOSED TO AQUATIC ENVIRONMENTS UNIVERSITY OF FLORIDA (US) 2005-03-17 — — WO claimed
WO-2005018307-A1 REDUCED-EXPOSURE TOBACCO PRODUCTS 22ND CENTURY LIMITED, LLC (US) 2005-03-03 — — WO claimed
US-20040235901-A1 Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments DUKE UNIVERSITY 2004-11-25 — — US claimed
US-5705512-A COGNITION ACTIVATORS USING PYRROLIDINE PYRIDINE SIBIA NEUROSCIENCES, INC. (US) 1998-01-06 — — US claimed
EP-0567251-B1 Treatment of neurodegenerative diseases REYNOLDS TOBACCO CO R (US) 1996-11-06 — — EP claimed
EP-0739342-A1 PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1996-10-30 — — EP claimed
WO-1996015123-A1 PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1996-05-23 — — WO claimed
US-5276043-A Anabasine compounds R. J. REYNOLDS TOBACCO COMPANY (US) 1994-01-04 — — US claimed
EP-0567251-A1 Treatment of neurodegenerative diseases R.J. REYNOLDS TOBACCO COMPANY (US) 1993-10-27 — — EP claimed
Send feedback